Aptose Biosciences Stock Price To Sales
| APS Stock | CAD 0.25 0.02 7.41% |
Aptose Biosciences fundamentals help investors to digest information that contributes to Aptose Biosciences' financial success or failures. It also enables traders to predict the movement of Aptose Stock. The fundamental analysis module provides a way to measure Aptose Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptose Biosciences stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 13.01 | 12.36 |
Aptose | Price To Sales |
Aptose Biosciences Company Price To Sales Analysis
Aptose Biosciences' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Aptose Biosciences Price To Sales | 12.36 |
Most of Aptose Biosciences' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aptose Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aptose Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Aptose Biosciences is extremely important. It helps to project a fair market value of Aptose Stock properly, considering its historical fundamentals such as Price To Sales. Since Aptose Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aptose Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aptose Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Aptose Price To Sales Ratio
Price To Sales Ratio |
|
Aptose Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aptose Biosciences from analyzing Aptose Biosciences' financial statements. These drivers represent accounts that assess Aptose Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aptose Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 19.0M | 23.9M | 8.0M | 3.6M | 3.2M | 4.6M | |
| Enterprise Value | (59.3M) | (92.4M) | (30.5M) | (32.1M) | (36.9M) | (35.1M) |
Aptose Fundamentals
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.36 | ||||
| Current Valuation | 4.35 M | ||||
| Shares Outstanding | 59.52 M | ||||
| Shares Owned By Insiders | 16.38 % | ||||
| Shares Owned By Institutions | 16.68 % | ||||
| Number Of Shares Shorted | 2.36 K | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 68.22 X | ||||
| EBITDA | (52.27 M) | ||||
| Net Income | (51.21 M) | ||||
| Cash And Equivalents | 36.37 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 1.01 M | ||||
| Debt To Equity | 5.00 % | ||||
| Current Ratio | 11.27 X | ||||
| Book Value Per Share | (0.36) X | ||||
| Cash Flow From Operations | (44.59 M) | ||||
| Short Ratio | 0.48 X | ||||
| Earnings Per Share | (4.09) X | ||||
| Target Price | 31.02 | ||||
| Number Of Employees | 35 | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 15.77 M | ||||
| Total Asset | 12.99 M | ||||
| Retained Earnings | (515.54 M) | ||||
| Working Capital | (3.38 M) | ||||
| Net Asset | 12.99 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
| 0.63 | BRK | Berkshire Hathaway CDR | PairCorr |
| 0.62 | BOFA | Bank of America | PairCorr |
| 0.6 | JPM | JPMorgan Chase | PairCorr |
| 0.53 | TD-PFD | Toronto Dominion Bank Earnings Call Tomorrow | PairCorr |
| 0.5 | AAPL | Apple Inc CDR | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.